Effects of transmembrane region variability on cell surface expression and allorecognition of HLA-DP3

被引:10
作者
Crivello, Pietro [1 ]
Lauterbach, Nina [2 ]
Zito, Laura [1 ]
Sizzano, Federico [3 ]
Toffalori, Cristina [1 ]
Marcon, Jessica [1 ]
Curci, Laura [1 ]
Mulder, Arend [4 ]
Wieten, Lotte [2 ]
Zino, Elisabetta [1 ]
Voorter, Christien E. M. [2 ]
Tilanus, Marcel G. J. [2 ]
Fleischhauer, Katharina [1 ]
机构
[1] Ist Sci San Raffaele, Unit Mol & Funct Immunogenet, I-20132 Milan, Italy
[2] Maastricht Univ Med Ctr, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands
[3] Ist Sci San Raffaele, Flow Cytometry Serv, I-20132 Milan, Italy
[4] Leiden Univ Med Ctr, Dept Immunohematol, Leiden, Netherlands
关键词
BONE-MARROW-TRANSPLANTATION; CLASS-II; MISMATCHES; ANTIGEN; EPITOPE; ALLELES; IMPACT; RECOGNITION; SUBSET; UNIT;
D O I
10.1016/j.humimm.2013.04.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The functional relevance of polymorphisms outside the peptide binding groove of HLA molecules is poorly understood. Here we have addressed this issue by studying HLA-DP3, a common antigen relevant for functional matching algorithms of unrelated hematopoietic stem cell transplantation (HSCT) encoded by two transmembrane (TM) region variants, DPB1*03:01 and DPB1*1 04:01. The two HLA-DP3 variants were found at a overall allelic frequency of 10.4% in 201 volunteer stem cell donors, at a ratio of 4.2:1. No significant differences were observed in cell surface expression levels of the two variants on B lymphoblastoid cell lines (BLCL), primary B cells or monocytes. Three different alloreactive T cell lines or clones showed similar levels of activation marker CD107a and/or CD137 upregulation in response to HLA-DP3 encoded by DPB1*03:01 and DPB1*104:01, either endogenously on BLCL or after lentiveral-vector mediated transfer into the same cellular background. These data provide, for the first time, direct evidence for a limited functional role of a TM region polymorphism on expression and allorecognition of HLA-DP3 and are compatible with the notion that the two variants can be considered as a single functional entity for unrelated stem cell donor selection. (C) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:970 / 977
页数:8
相关论文
共 33 条
[1]   Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters [J].
Amendola, M ;
Venneri, MA ;
Biffi, A ;
Vigna, E ;
Naldini, L .
NATURE BIOTECHNOLOGY, 2005, 23 (01) :108-116
[2]  
ARROYO J, 1994, IMMUNOGENETICS, V39, P40
[3]   Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P [J].
Bade-Doeding, Christina ;
Cano, Pedro ;
Huyton, Trevor ;
Badrinath, Soumya ;
Eiz-Vesper, Britta ;
Hiller, Oliver ;
Blasczyk, Rainer .
HUMAN IMMUNOLOGY, 2011, 72 (11) :1039-1044
[4]   Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation [J].
Betts, MR ;
Brenchley, JM ;
Price, DA ;
De Rosa, SC ;
Douek, DC ;
Roederer, M ;
Koup, RA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 281 (1-2) :65-78
[5]   Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation [J].
Crocchiolo, Roberto ;
Zino, Elisabetta ;
Vago, Luca ;
Oneto, Rosi ;
Bruno, Barbara ;
Pollichieni, Simona ;
Sacchi, Nicoletta ;
Sormani, Maria Pia ;
Marcon, Jessica ;
Lamparelli, Teresa ;
Fanin, Renato ;
Garbarino, Lucia ;
Miotti, Valeria ;
Bandini, Giuseppe ;
Bosi, Alberto ;
Ciceri, Fabio ;
Bacigalupo, Andrea ;
Fleischhauer, Katharina ;
Scalari, P. ;
Bontempelli, M. ;
Prinoth, O. ;
Carcassi, C. ;
Marceno, R. ;
Porfirio ;
Rombola, G. ;
Garbarino, L. ;
Lombardo ;
Ferrioli, G. ;
Poli, F. ;
Scalamogna, M. ;
Fleischhauer, K. ;
Mazzi, B. ;
Rossi, F. ;
Mascaretti, L. ;
Albergoni ;
Salvaneschi, L. ;
Martinetti, M. ;
Valentini ;
Nesci, S. ;
Papola, F. ;
Scatena ;
Mariotti ;
Perrone ;
Laurenti ;
Grammatico, P. ;
Mariani, M. ;
Favoino, B. ;
Miotti, V. ;
Guizzardi ;
Pontiero .
BLOOD, 2009, 114 (07) :1437-1444
[6]   The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells [J].
Davis, DM ;
Mandelboim, O ;
Luque, I ;
Baba, E ;
Boyson, J ;
Strominger, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1265-1274
[7]   A "silent" nucleotide substitution in exon 4 is responsible for the "alternative expression" of HLA-A*01:01:38L through aberrant splicing [J].
Dunn, Paul P. J. ;
Hammond, Laura ;
Coates, Ernest ;
Street, Jane ;
Griner, Leon ;
Darke, Christopher .
HUMAN IMMUNOLOGY, 2011, 72 (09) :717-722
[8]   Immunogenetics of HLA null alleles: implications for blood stem cell transplantation [J].
Elsner, HA ;
Blasczyk, R .
TISSUE ANTIGENS, 2004, 64 (06) :687-695
[9]   Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain [J].
Ferrara, GB ;
Bacigalupo, A ;
Lamparelli, T ;
Lanino, E ;
Delfino, L ;
Morabito, A ;
Parodi, AM ;
Pera, C ;
Pozzi, S ;
Sormani, MP ;
Bruzzi, P ;
Bordo, D ;
Bolognesi, M ;
Bandini, G ;
Bontadini, A ;
Barbanti, M ;
Frumento, G .
BLOOD, 2001, 98 (10) :3150-3155
[10]   Peripheral blood stem cell allograft rejection mediated by CD4+ T lymphocytes recognizing a single mismatch at HLA-DPβ1*0901 [J].
Fleischhauer, K ;
Zino, E ;
Mazzi, B ;
Sironi, E ;
Servida, P ;
Zappone, E ;
Benazzi, E ;
Bordignon, C .
BLOOD, 2001, 98 (04) :1122-1126